Literature DB >> 30364209

Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis.

Nattapong Mekhasingharak1, Poramaet Laowanapiban2, Sasitorn Siritho3,4, Chanjira Satukijchai3,5, Naraporn Prayoonwiwat3, Jiraporn Jitprapaikulsan3, Niphon Chirapapaisan6.   

Abstract

AIM: To compare the thickness of the peripapillary retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GCIPL) among patients with various forms of optic neuritis (ON) and to identify whether any particular parameters or their thinning pattern can be used to distinguish the type of ON.
METHODS: This prospective study was conducted at the Department of Ophthalmology, Faculty of Medicine, Siriraj Hospital, Thailand, between January, 2015 and December, 2016. We enlisted patients over 18 years of age with history of ON and categorized patients into 4 groups: 1) aquaporin 4 antibodies (AQP4-IgG) positive; 2) multiple sclerosis (MS); 3) myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) positive; 4) idiopathic-ON patients. Healthy controls were also included during the same study period. All patients underwent complete ophthalmological examination and spectral domain optical coherence tomography (OCT) imaging to analyze RNFL and GCIPL thickness after at least 3mo since the last episode of acute ON. The generalized estimating equation (GEE) models were used to compare the data amongst ON groups.
RESULTS: Among 87 previous ON eyes from 57 patients (43 AQP4-IgG+ON, 17 MS-ON, 8 MOG-IgG+ON, and 19 idiopathic-ON), mean logMAR visual acuity of AQP4-IgG+ON, MS-ON, MOG-IgG+ON, and idiopathic-ON groups was 0.76±0.88, 0.12±0.25, 0.39±0.31, and 0.75±1.08, respectively. Average, superior, and inferior RNFL were significantly reduced in AQP4-IgG+ON, MOG-IgG+ON and idiopathic-ON eyes, relative to those of MS-ON. Differences were not statistically significant for RNFL or GCIPL between the AQP4-IgG+ON and MOG-IgG+ON groups, whereas visual acuity in MOG-IgG+ON was slightly, but not significantly, better (0.39 vs 0.76). Although RNFL thickness in MOG-IgG+ON was significantly reduced as compared to MS-ON, mean visual acuity and GCIPL were not different.
CONCLUSION: Thinning of superior and inferior quadrants of RNFL are more commonly seen in MOG-IgG+ON and AQP4-IgG+ON. Long term visual acuity in MOG-IgG+ON is often better than AQP4-IgG+ON, whereas the structural change from OCT is comparable.

Entities:  

Keywords:  multiple sclerosis; myelin oligodendrocyte glycoprotein antibody; neuromyelitis optica; optic neuritis; optical coherence tomography

Year:  2018        PMID: 30364209      PMCID: PMC6192964          DOI: 10.18240/ijo.2018.10.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  43 in total

1.  Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.

Authors:  Ju-Hong Min; Byoung Joon Kim; Kwang Ho Lee
Journal:  Mult Scler       Date:  2011-12-06       Impact factor: 6.312

2.  Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients.

Authors:  Markus Bock; Alexander U Brandt; Jan Dörr; Helga Kraft; Nicholetta Weinges-Evers; Gunnar Gaede; Caspar F Pfueller; Katja Herges; Helena Radbruch; Stephanie Ohlraun; Judith Bellmann-Strobl; Jörn Kuchenbecker; Frauke Zipp; Friedemann Paul
Journal:  Clin Neurol Neurosurg       Date:  2010-05-10       Impact factor: 1.876

Review 3.  Spectral domain optical coherence tomography in the diagnosis and management of glaucoma.

Authors:  Ahmad A Aref; Donald L Budenz
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010 Nov-Dec

4.  A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.

Authors:  Olivier Outteryck; Bilal Majed; Sabine Defoort-Dhellemmes; Patrick Vermersch; Hélène Zéphir
Journal:  Mult Scler       Date:  2015-03-31       Impact factor: 6.312

5.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

6.  Ganglion cell analysis in acute optic neuritis.

Authors:  R Behbehani; A Al-Moosa; D Sriraman; R Alroughani
Journal:  Mult Scler Relat Disord       Date:  2015-10-31       Impact factor: 4.339

7.  Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

Authors:  C Papeix; J-S Vidal; J de Seze; C Pierrot-Deseilligny; A Tourbah; B Stankoff; C Lebrun; T Moreau; P Vermersch; B Fontaine; O Lyon-Caen; O Gout
Journal:  Mult Scler       Date:  2007-01-29       Impact factor: 6.312

8.  Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.

Authors:  Masahiko Nakamura; Toru Nakazawa; Hiroshi Doi; Takehiro Hariya; Kazuko Omodaka; Tatsuro Misu; Toshiyuki Takahashi; Kazuo Fujihara; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-19       Impact factor: 3.117

Review 9.  Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Authors:  J L Bennett; J de Seze; M Lana-Peixoto; J Palace; A Waldman; S Schippling; S Tenembaum; B Banwell; B Greenberg; M Levy; K Fujihara; K H Chan; H J Kim; N Asgari; D K Sato; A Saiz; J Wuerfel; H Zimmermann; A Green; P Villoslada; F Paul
Journal:  Mult Scler       Date:  2015-02-06       Impact factor: 6.312

10.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

View more
  4 in total

1.  Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode.

Authors:  T Pakeerathan; J Havla; C Schwake; A Salmen; S Bigi; M Abegg; D Brügger; T Ferrazzini; A-K Runge; M Breu; B Kornek; G Bsteh; A Felipe-Rucián; M Ringelstein; O Aktas; M Karenfort; E Wendel; I Kleiter; K Hellwig; T Kümpfel; C Thiels; T Lücke; R Gold; K Rostasy; I Ayzenberg
Journal:  J Neurol       Date:  2022-07-23       Impact factor: 6.682

2.  Detailed Evaluation of Macular Ganglion Cell Complex in Patients with Multiple Sclerosis.

Authors:  Kemal Turgay Özbilen; Tuncay Gündüz; Selva Nur Çukurova Kartal; Nihan Aksu Ceylan; Mefküre Eraksoy; Murat Kürtüncü
Journal:  Noro Psikiyatr Ars       Date:  2021-08-26       Impact factor: 1.339

3.  Correlation Between Retrograde Trans-Synaptic Degeneration of Ganglion Cells and Optical Coherence Tomography Angiography Following Ischemic Stroke.

Authors:  Mercedes Molero-Senosiain; Beatriz Vidal-Villegas; Javier Pascual-Prieto; Clara Valor-Suarez; Federico Saenz-Frances; Enrique Santos-Bueso
Journal:  Cureus       Date:  2021-11-21

Review 4.  Clinical and neuroimaging findings in MOGAD-MRI and OCT.

Authors:  Frederik Bartels; Angelo Lu; Frederike Cosima Oertel; Carsten Finke; Friedemann Paul; Claudia Chien
Journal:  Clin Exp Immunol       Date:  2021-07-18       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.